CDIB Capital International Overview

  • Investor Type
  • PE/​Buyout

  • Status
  • Active

  • Professionals
  • 25

Professionals

  • Investments
  • 97

  • Portfolio
  • 32

  • Exits
  • 42

Exits

CDIB Capital International General Information

Company Description

Founded in 2006, CDIB Capital International is a private equity investment arm of China Development Financial based in Hong Kong. The firm specializes in middle-market buyouts, recapitalization, corporate divestiture, growth equity investment, and mid-to-late-stage venture capital transactions.

Business Details

Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Other Investor Types
Corporate Venture Capital
Growth/Expansion
Venture Capital
Corporate Office
  • 7th Floor ICBC Tower
  • 3 Garden Road, Central
  • Hong Kong
  • Hong Kong
+852 2231

CDIB Capital International Investments & Acquisitions (97)

CDIB Capital International’s most recent investment was a with Affection Animal Pharmaceuticals for . The deal was made on 01-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Affection Animal Pharmaceuticals 01-Jan-2025 Other Commercial Products Clinical Trials - General
Laffon 28-Jun-2024 Other Apparel Generating Revenue
TXOne Networks 08-May-2024 Network Management Software Generating Revenue
Rivos 16-Apr-2024 General Purpose Semiconductors Generating Revenue
Arthrone Technology 25-Aug-2023 Later Stage VC Therapeutic Devices Generating Revenue
You’re viewing 5 of 97 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CDIB Capital International Exits (42)

CDIB Capital International has made a total of 42 exits. Its latest exit was from TYK Medicines for on 20-Aug-2024. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
TYK Medicines 20-Aug-2024
Acepodia 08-Aug-2023
Housing Development Finance Corporation 01-Jul-2023
ACT Genomics 30-Dec-2022
MCM (Clothing) 01-Oct-2022 Secondary Transaction - Private
You’re viewing 5 of 42 exits. Get the full list »

CDIB Capital International Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

CDIB Capital International FAQs

  • What is CDIB Capital International?

    Founded in 2006, CDIB Capital International is a private equity investment arm of China Development Financial based in Hong Kong.

  • When was CDIB Capital International founded?

    CDIB Capital International was founded in 2006.

  • Where is CDIB Capital International headquartered?

    CDIB Capital International is headquartered in Hong Kong, Hong Kong.

  • What is CDIB Capital International's total asset value?

    CDIB Capital International has around in total assets under management.

  • How many investments has CDIB Capital International made?

    CDIB Capital International has made 97 investments.

  • What has CDIB Capital International invested in?

    CDIB Capital International has made numerous investments in companies like Affection Animal Pharmaceuticals, Laffon, and TXOne Networks within the Commercial Products, Apparel, and Network Management Software industries.

  • What has CDIB Capital International invested in recently?

    CDIB Capital International's latest investment was on 01-Jan-2025 in Affection Animal Pharmaceuticals, a company within the Commercial Products industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »